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Introduction
Hepcidin - 25-amino acid peptide - is known to be a key
regulator of systemic iron metabolism [Ganz T., Nemeth
E., 2012]. Hepcidin acts indirectly through ferroportin,
which is both a receptor for hepcidin and the only known
exporter of iron in the human body [De Falco L. et. al.,
2013]. Hyperproduction of hepcidin due to the influence
of pro-inflammatory cytokines, especially IL-6, triggers to
transport of iron from circulation to the storage, conse-
quently, limiting iron accessibility for erythropoiesis
[Weiss G., Goodnought T., 2005]. Thus, overproduction
of hepcidin seems to be the leading mechanism of devel-
opment of anemia in children with Juvenile Idiopathic
Arthritis (JIA). A set of negative factors of a chronic dis-
ease, particularly disbalance of vitamins, proteins, amino
acids and minerals, which are also the known causes, of
anemia can weaken control of iron metabolism by
hepcidin.
Objectives
To determine how strong are the correlations of serum
hepcidin level with clinical and laboratory characteristics
of arthritis and iron metabolism in children with JIA.
Methods
Ten children (8 girls and 2 boys, average age 10.2 ±
4.5 years) with 2-5 year long course of the polyarticular
JIA have been enrolled in the study. Patients underwent
a complete clinical and laboratory examination before
treatment and at weeks 4 and 16 of the study. Clinical
examination included the evaluation of articular syn-
drome, assessment of disease activity and efficacy of the
treatment using the ACRpedi-scale. The set of laboratory
data included the complete blood count with erythrocyte
indices: mean corpuscular volume (MCV), mean corpus-
cular hemoglobin (MCH) and mean corpuscular hemo-
globin concentration (MCHC). Erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP) were used as
markers of inflammatory activity. Serum levels of ferritin,
iron, total iron binding capacity (TIBC), transferrin
saturation (TSAT), soluble transferrin receptor (sTfR)
and hepcidin were used to assess the iron metabolism.
Linear regression and Spearman’s rank coefficient were
used to describe correlations.
Results
Serum concentration of hepcidin correlated with the
inflammatory activity indices. We revealed correlation
(p<0.02) of serum hepcidin concentration with the num-
ber of swollen joints (rs=+0.60), the number of painful
joints (rs=+0.71), with ESR (rs=+0.63), with the level of
CRP (rs=+0.87), with leukocyte (rs=+0.89), platelet
(rs=+0.89) and neutrophil blood cell counts (rs=+0.79).
Rather strong correlation of serum levels of hepcidin and
ferritin (rs=+0.90), sTfR (rs=+0.51), iron (rs= - 0.49) and
TIBC (rs= - 0.50) as well as with MCV (rs= - 0.63)
and with MCH (rs= - 0.62) was also revealed. MCH was
found to be the most sensitive to the level of serum hepci-
din parameter, much more sensitive than total hemoglobin
concentration.
Conclusion
The study revealed strong correlation of the serum hepci-
din level with both clinical and laboratory indicators of the
inflammatory activity of arthritis, as well as with indicators
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anemia in JIA-children is almost exclusively controlled by
hepcidin and is caused by disturbance of iron metabolism
with the development of iron-restricted erythropoiesis.
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